Authorities Cited: United States Code 15 U.S.C. § 1392(d) 15 U.S.C. § 1397(k) 21 U.S.C. § 301 21 U.S.C. § 331(a) 21 U.S.C. § 355(d) 21 U.S.C. § 355(d)(7) 21 U.S.C. § 355(e) 21 U.S.C. § 355(j) 21 U.S.C. § 355(j)(2)(A)(iv) 21 U.S.C. § 360(k)(a) 21 U.S.C. § 393(b)(1) 28 U.S.C. § 1291 28 U.S.C. § 1292(b) 28 U.S.C. § 1332 35 U.S.C. § 156 35 U.S.C. § 271 35 U.S.C. § 281 Code of Federal Regulations 21 C.F.R. § 201.56 21 C.F.R. § 201.57 21 C.F.R. § 201.57(e) 21 C.F.R. § 201.80(e) 21 C.F.R. § 314.105(b) 21 C.F.R. § 314.150(b)(10) 21 C.F.R. § 314.50(c)(2)(i) 21 C.F.R. § 314.50(d)(5) 21 C.F.R. § 314.70 21 C.F.R. § 314.70(b) 21 C.F.R. § 314.70(c)(6) 21 C.F.R. § 314.80(c) 21 C.F.R. § 314.80(j) 21 C.F.R. § 314.81(b)(2)(i) 21 C.F.R. § 314.81(d) 49 C.F.R. § 571.212 Supreme Court 21 U.S. 504, 516 228 U.S. 115, 127 312 U.S. 52, 67 323 U.S. 134 331 U.S. 218, 230 335 U.S. 345, 350 373 U.S. 132, 143 450 U.S. 311, 327 458 U.S. 141, 154-162 463 U.S. 29 471 U.S. 707, 713-720 486 U.S. 57, 64 496 U.S. 72, 79-80 505 U.S. 504, 516-530 514 U.S. 280, 287 517 U.S. 25, 31 518 U.S. 470, 474-505 519 U.S. 452, 461 524 U.S. 214, 228 529 U.S. 89, 94 529 U.S. 576, 587 529 U.S. 861, 864-885 531 U.S. 341, 343-348 533 U.S. 218, 228 537 U.S. 51, 58-67 544 U.S. 431, 449-450 Circuit Courts 159 F.2d 169, 173 160 F.2d 482 895 F.2d 1488, 1497-1499 91 F.3d 1493, 1494 267 F.3d 288, 295 358 F.3d 659 376 F.3d 163, 166-178 457 F.3d 274, 283-284 458 F.3d 244, 256 499 F.3d 239, 242 503 F.3d 256, 273 432 F. Supp. 2d 514, 523-539

Blogged: How Appealing Divided three-judge Third Circuit panel issues FDA preemption ruling in cases alleging a failure to warn of increased risk of suicide for patients taking Paxil or Zoloft How Appealing Available online from law.com How Appealing "Appellate ruling favors drug firms in lawsuits"